Plains GP (NYSE:PAGP) PT Raised to $20.00

Plains GP (NYSE:PAGP – Get Free Report) had its target price raised by research analysts at Morgan Stanley from $19.00 to $20.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has an “overweight” rating on the pipeline company’s stock. Morgan Stanley’s target price would suggest a potential […]

Leave a Reply

Your email address will not be published.

Previous post Head to Head Review: Ainos (OTCMKTS:AIMD) vs. Bone Biologics (OTC:BBLG)
Next post Zions Bancorporation, National Association (NASDAQ:ZION) Downgraded to Sell at StockNews.com